{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:57:45Z","timestamp":1773813465807,"version":"3.50.1"},"reference-count":55,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The C57BL\/6.NOD-Aec1Aec2 mouse model has been extensively studied to define the underlying cellular and molecular bioprocesses critical in the onset of primary Sj\u00f6gren\u2019s Syndrome (pSS), a human systemic autoimmune disease characterized clinically as the loss of lacrimal and salivary gland functions leading to dry eye and dry mouth pathologies. This mouse model, together with several gene knockout mouse models of SS, has indicated that B lymphocytes, especially marginal zone B (MZB) cells, are necessary for development and onset of clinical manifestations despite the fact that destruction of the lacrimal and salivary gland cells involves a classical T cell-mediated autoimmune response. Because migrations and functions of MZB cells are difficult to study in vivo, we have carried out ex vivo investigations that use temporal global RNA transcriptomic analyses to profile autoimmunity as it develops within the salivary glands of C57BL\/6.NOD-Aec1Aec2 mice. Temporal profiles indicate the appearance of Notch2-positive cells within the salivary glands of these SS-susceptible mice concomitant with the early-phase appearance of lymphocytic foci (LF). Data presented here identify cellular bioprocesses occurring during early immune cell migrations into the salivary glands and suggest MZB cells are recruited to the exocrine glands by the upregulated Cxcl13 chemokine where they recognize complement (C\u2019)-decorated antigens via their sphingosine-1-phosphate (S1P) and B cell (BC) receptors. Based on known MZB cell behavior and mobility, we propose that MZB cells activated in the salivary glands migrate to splenic follicular zones to present antigens to follicular macrophages and dendritic cells that, in turn, promote a subsequent systemic cell-mediated and autoantibody-mediated autoimmune T cell response that targets exocrine gland cells and functions. Overall, this study uses the power of transcriptomic analyses to provide greater insight into several molecular events defining cellular bioprocesses underlying SS that can be modelled and more thoroughly studied at the cellular level.<\/jats:p>","DOI":"10.3390\/ijms22041919","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T05:52:49Z","timestamp":1613368369000},"page":"1919","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sj\u00f6gren\u2032s Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease"],"prefix":"10.3390","volume":"22","author":[{"given":"Ammon B.","family":"Peck","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5633-4075","authenticated-orcid":false,"given":"Cuong Q.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4505-796X","authenticated-orcid":false,"given":"Julian","family":"Ambrus","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology and Rheumatology, SUNY Buffalo School of Medicine, Buffalo, NY 14023, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"ref_1","first-page":"3","article-title":"Crossroads of B cell activation in autoimmunity: Rationale of targeting B cells","volume":"77","year":"2006","journal-title":"J. Rheumatol. Suppl."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fimmu.2018.00835","article-title":"Targeting B Cells and Plasma Cells in Autoimmune Diseases","volume":"9","author":"Hofmann","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.semarthrit.2018.10.007","article-title":"Regulatory B cells: New players in inflammatory and autoimmune rheumatic diseases","volume":"48","author":"Sakkas","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ma, K., Du, W., Wang, X., Yuan, S., Cai, X., Liu, D., Li, J., and Lu, L. (2019). Multiple Functions of B Cells in the Pathogenesis of Systemic Lupus Erythematosus. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20236021"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imr.12815","article-title":"Autoreactive B cells in SLE, villains or innocent bystanders?","volume":"292","author":"Hamilton","year":"2019","journal-title":"Immunol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/1744666X.2014.891439","article-title":"B-cell hyperactivity in primary Sjogren\u2019s syndrome","volume":"10","author":"Kroese","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","article-title":"Early diagnosis of primary Sj\u00f6gren\u2019s syndrome: EULAR-SS task force clinical recommendations","volume":"12","author":"Theander","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2741\/2187","article-title":"Sjogren\u2019s syndrome (SjS)-like disease of mice: The importance of B lymphocytes and autoanti-bodies","volume":"12","author":"Nguyen","year":"2007","journal-title":"Front. Biosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1097\/SCS.0b013e3182902ef4","article-title":"Different Lymphoproliferative Disorders in Different Salivary Glands of Primary Sj\u00f6gren Syndrome","volume":"24","author":"Zheng","year":"2013","journal-title":"J. Craniofacial Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/annrheumdis-2016-210448","article-title":"Standardisation of labial salivary gland histopathology in clinical trials in primary Sjogren\u2019s syndrome","volume":"76","author":"Fisher","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3313","article-title":"Sjogren\u2019s syndrome: Studying the disease in mice","volume":"13","author":"Delaleu","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T","article-title":"A novel NOD-derived murine model of primary Sjogren\u2019s syndrome","volume":"41","author":"Robinson","year":"1998","journal-title":"Arthritis Rheum."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.10258","article-title":"Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjogren\u2019s syndrome) on a healthy murine background","volume":"46","author":"Cha","year":"2002","journal-title":"Arthritis Rheum."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.4049\/jimmunol.177.8.5676","article-title":"Development of Autoimmunity in IL-14\u03b1-Transgenic Mice","volume":"177","author":"Shen","year":"2006","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clim.2017.05.001","article-title":"What can Sjogren\u2019s syndrome-like disease in mice contribute to human Sjogren\u2019s syndrome?","volume":"182","author":"Peck","year":"2017","journal-title":"Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","article-title":"Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren\u2019s syndrome","volume":"95","author":"Robinson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","article-title":"The BAFF\/APRIL system: Emerging functions beyond B cell biology and autoimmunity","volume":"24","author":"Vincent","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clim.2016.06.007","article-title":"BAFF overexpression increases lymphocytic infiltration in Sjogren\u2019s target tissue, but only inefficiently promotes ectopic B-cell differentiation","volume":"169","author":"Ding","year":"2016","journal-title":"Clin. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clim.2016.01.015","article-title":"Early BAFF receptor blockade mitigates murine Sjogren\u2019s syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction","volume":"164","author":"Sharma","year":"2016","journal-title":"Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.clim.2008.10.006","article-title":"IL-14 alpha, the nexus for primary Sjogren\u2019s disease in mice and humans","volume":"130","author":"Shen","year":"2009","journal-title":"Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.4049\/jimmunol.1001520","article-title":"A Role for Lymphotoxin in Primary Sjogren\u2019s Disease","volume":"185","author":"Shen","year":"2010","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nri799","article-title":"Marginal-zone B cells","volume":"2","author":"Martin","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri3383","article-title":"Marginal zone B cells: Virtues of innate-like antibody-producing lymphocytes","volume":"13","author":"Cerutti","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12016-019-08740-1","article-title":"The Innate Part of the Adaptive Immune System","volume":"58","author":"Hillion","year":"2019","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2016.04.008","article-title":"Central role for marginal zone B cells in an animal model of Sjogren\u2019s syndrome","volume":"168","author":"Shen","year":"2016","journal-title":"Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/labinvest.3700487","article-title":"Early pathogenic events associated with Sjogren\u2019s syndrome (SjS)-like disease of the NOD mouse using microarray analysis","volume":"86","author":"Killedar","year":"2006","journal-title":"Lab. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2676","article-title":"Differential gene expression in the salivary gland during development and onset of xerostomia in Sjogren\u2019s syn-drome-like disease of the C57BL\/6.NOD-Aec1Aec2 mouse","volume":"11","author":"Nguyen","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.exer.2008.10.006","article-title":"Differential gene expressions in the lacrimal gland during development and onset of keratoconjunctivitis sicca in Sjogren\u2019s syndrome (SJS)-like disease of the C57BL\/6.NOD-Aec1Aec2 mouse","volume":"88","author":"Nguyen","year":"2009","journal-title":"Exp. Eye Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-3083.2012.02749.x","article-title":"Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjogren\u2019s syn-drome","volume":"76","author":"Peck","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar4362","article-title":"Transcriptional landscapes of emerging autoimmunity: Transient aberrations in the targeted tissue\u2019s extracellular milieu precede immune responses in Sj\u00f6gren\u2019s syndrome","volume":"15","author":"Delaleu","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1542-0124(12)70289-6","article-title":"Unraveling the pathophysiology of Sjogren\u2019s syndrome-associated dry eye disease","volume":"7","author":"Nguyen","year":"2009","journal-title":"Ocul. Surf."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-3083.2006.01828.x","article-title":"Sjogren\u2019s syndrome-like disease of C57BL\/6.NOD-Aec1Aec2 mice: Gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus","volume":"64","author":"Nguyen","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"ref_34","first-page":"4","article-title":"The interferon-signature of Sjogren\u2019s syndrome: How unique biomarkers can identify underlying inflammatory and immunopathological mechanisms of specific diseases","volume":"5","author":"Nguyen","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/4813795","article-title":"Sjogren\u2019s Syndrome and TAM Receptors: A Possible Contribution to Disease Onset","volume":"2019","author":"Witas","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1167\/iovs.11-7652","article-title":"Gene Expression Profiling of Early-Phase Sjogren\u2019s Syndrome in C57BL\/6.NOD-Aec1Aec2 Mice Identifies Focal Adhesion Maturation Associated with Infiltrating Leukocytes","volume":"52","author":"Peck","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/cei.12643","article-title":"Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren\u2019s syndrome and Sjogren-associated non-Hodgkin lymphomas and is regulated by IL-18","volume":"181","author":"Ciccia","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nri2454","article-title":"The who, how and where of antigen presentation to B cells","volume":"9","author":"Batista","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ni.3657","article-title":"Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10","volume":"18","author":"Hammad","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3389\/fonc.2018.00550","article-title":"The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies","volume":"8","author":"Arruga","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1074-7613(00)80157-0","article-title":"Positive Selection from Newly Formed to Marginal Zone B Cells Depends on the Rate of Clonal Production, CD19, and btk","volume":"12","author":"Martin","year":"2000","journal-title":"Immunity"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.4049\/jimmunol.175.12.8173","article-title":"Defective Microarchitecture of the Spleen Marginal Zone and Impaired Response to a Thymus-Independent Type 2 Antigen in Mice Lacking Scavenger Receptors MARCO and SR-A","volume":"175","author":"Chen","year":"2005","journal-title":"J. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.1071632","article-title":"Integrin-mediated long-term B cell retention in the splenic marginal zone","volume":"297","author":"Lu","year":"2002","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1084\/jem.20030684","article-title":"Macrophages Control the Retention and Trafficking of B Lymphocytes in the Splenic Marginal Zone","volume":"198","author":"Karlsson","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ni1083","article-title":"Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone","volume":"5","author":"Cinamon","year":"2004","journal-title":"Nat. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ni1542","article-title":"Follicular shuttling of marginal zone B cells facilitates antigen transport","volume":"9","author":"Cinamon","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ni0901-855","article-title":"Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses","volume":"2","author":"Girkontaite","year":"2001","journal-title":"Nat. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/s41467-017-02482-4","article-title":"The opposing forces of shear flow and sphingosine-1-phosphate control marginal zone B cell shuttling","volume":"8","author":"Tedford","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate\u2014A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B-Methodol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.molimm.2005.09.003","article-title":"Role of complement and B lymphocytes in Sjogren\u2019s syndrome-like autoimmune exocrinopathy of NOD.B10-H2(B) mice","volume":"43","author":"Nguyen","year":"2006","journal-title":"Mol. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-3083.2001.00958.x","article-title":"IL-4-Dependent Effector Phase in Autoimmune Exocrinopathy as Defined by the NOD.IL-4-Gene Knockout Mouse Model of Sjogren\u2019s Syndrome","volume":"54","author":"Brayer","year":"2001","journal-title":"Scand. J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2005.11.004","article-title":"Sjogren\u2019s syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease","volume":"26","author":"Gao","year":"2006","journal-title":"J. Autoimmun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.0300-9475.2004.01508.x","article-title":"A dual role for interferon-gamma in the pathogenesis of Sjogren\u2019s syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse","volume":"60","author":"Cha","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.immuni.2005.08.007","article-title":"Evidence of Marginal-Zone B Cell- Positive Selection in Spleen","volume":"23","author":"Wen","year":"2005","journal-title":"Immunity"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/1919\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:24:24Z","timestamp":1760160264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/4\/1919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["ijms22041919"],"URL":"https:\/\/doi.org\/10.3390\/ijms22041919","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]}}}